BofA analyst Kevin Fischbeck downgraded Humana to Underperform from Neutral with a price target of $247, down from $376.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- BofA double downgrades Agilon Health to Underperform on impaired visibility
- Humana falls -17.6%
- Baird sees ‘material’ EPS headwind for Humana on ‘worst case’ Star scenario
- Humana likely to revise downward MA enrollment views for 2025, says RBC Capital
- J.P. Morgan Weighs in on Humana Stock Following Medicare Star Rating Changes
Questions or Comments about the article? Write to editor@tipranks.com